We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
(+21%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
9.89%
Top 10 Holdings %
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$34M |
| 2 |
ExxonMobil
XOM
|
+$33.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$32.7M |
| 4 |
3M
MMM
|
+$32.4M |
| 5 |
McDonald's
MCD
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70M |
| 2 |
W.R. Berkley
WRB
|
+$12.8M |
| 3 |
ISCA
International Speedway Corp
ISCA
|
+$11.2M |
| 4 |
CTWS
Connecticut Water Service Inc
CTWS
|
+$11.2M |
| 5 |
Gen Digital
GEN
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Financials | 12.4% |
| 3 | Industrials | 11.69% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Staples | 11.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
EnerSys
ENS
$6.95B
| $716K | ﹤0.01% |
9,565
+1,319
| +16% | +$91.4K |
|
927
Pacira BioSciences
PCRX
$1.02B
| $712K | ﹤0.01% |
15,727
-1,213
| -7% | -$51.5K |
|
928
Interactive Brokers
IBKR
$40.9B
| $708K | ﹤0.01% |
60,752
+1,724
| +3% | +$20.2K |
|
|
RARX
929
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $700K | ﹤0.01% |
14,913
-1,779
| -11% | -$78.6K |
|
930
TD Synnex
SNX
$19.4B
| $699K | ﹤0.01% |
10,854
+826
| +8% | +$49.8K |
|
931
Associated Banc-Corp
ASB
$5.81B
| $696K | ﹤0.01% |
31,569
+338
| +1% | +$7.13K |
|
932
Credit Acceptance
CACC
$6B
| $696K | ﹤0.01% |
1,574
-54
| -3% | -$23.8K |
|
|
MFA
933
MFA Financial
MFA
$929M
| $696K | ﹤0.01% |
22,734
-827
| -4% | -$25.2K |
|
934
Apple Hospitality REIT
APLE
$3.96B
| $689K | ﹤0.01% |
42,372
-1,659
| -4% | -$26.8K |
|
935
Xencor
XNCR
$1.44B
| $689K | ﹤0.01% |
20,034
-1,925
| -9% | -$70.3K |
|
|
PTLA
936
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $689K | ﹤0.01% |
28,844
-2,318
| -7% | -$63.9K |
|
937
Kennametal
KMT
$2.68B
| $684K | ﹤0.01% |
18,543
+2,615
| +16% | +$87.5K |
|
|
CZR
938
DELISTED
Caesars Entertainment Corporation
CZR
| $679K | ﹤0.01% |
49,958
+5,619
| +13% | +$71.1K |
|
939
uniQure
QURE
$2.68B
| $676K | ﹤0.01% |
9,432
-813
| -8% | -$44.6K |
|
940
Manhattan Associates
MANH
$8.97B
| $675K | ﹤0.01% |
8,463
+602
| +8% | +$47.9K |
|
|
VRNT
941
DELISTED
Verint Systems
VRNT
| $675K | ﹤0.01% |
23,933
+3,227
| +16% | +$78.6K |
|
|
LHCG
942
DELISTED
LHC Group LLC
LHCG
| $674K | ﹤0.01% |
4,895
+716
| +17% | +$89.1K |
|
943
Cable One
CABO
$213M
| $668K | ﹤0.01% |
449
+50
| +13% | +$70.9K |
|
|
ESGR
944
DELISTED
Enstar Group
ESGR
| $668K | ﹤0.01% |
3,229
+192
| +6% | +$38.4K |
|
|
ISBC
945
DELISTED
Investors Bancorp, Inc.
ISBC
| $668K | ﹤0.01% |
56,061
+3,473
| +7% | +$41.6K |
|
|
GWPH
946
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $666K | ﹤0.01% |
6,374
-1,592
| -20% | -$179K |
|
947
Ashland
ASH
$3.04B
| $663K | ﹤0.01% |
8,658
+115
| +1% | +$8.73K |
|
948
Lear
LEA
$7.19B
| $663K | ﹤0.01% |
+4,835
| New | +$599K |
|
|
AIMT
949
DELISTED
Aimmune Therapeutics
AIMT
| $662K | ﹤0.01% |
19,790
-2,234
| -10% | -$62.5K |
|
950
Carpenter Technology
CRS
$30B
| $660K | ﹤0.01% |
13,249
+1,153
| +10% | +$59.2K |
|
Similar funds
ProShare Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.
- ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
- ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
- ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
- ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
- ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
- ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
- ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.
Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.